naltrexone has been researched along with binaltorphimine in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (9.52) | 18.7374 |
1990's | 21 (50.00) | 18.2507 |
2000's | 7 (16.67) | 29.6817 |
2010's | 7 (16.67) | 24.3611 |
2020's | 3 (7.14) | 2.80 |
Authors | Studies |
---|---|
Larson, DL; Lipkowski, AW; Nagase, H; Portoghese, PS; Takemori, AE | 1 |
Robinson, SR; Smotherman, WP | 1 |
Maier, SF; Watkins, LR; Wiertelak, EP | 2 |
Blackford, SP; Kuhn, CM; Little, PJ | 1 |
Derrick, BE; Lieberman, DN; Martinez, JL; Rodriguez, SB | 1 |
Faden, AI; Portoghese, PS; Vink, R | 1 |
Song, ZH; Takemori, AE | 1 |
Chen, DC; Quock, RM | 1 |
Kaneto, H; Senda, T; Takahashi, M; Tokuyama, S | 1 |
de Costa, B; Long, JB; Martinez-Arizala, A; Rice, KC; Rigamonti, DD | 1 |
Almeida, OF; Herz, A; Nikolarakis, KE; Webley, GE | 1 |
Lipkowski, AW; Portoghese, PS; Takemori, AE | 1 |
Crain, SM | 1 |
Bélisle, S; Bellabarba, D; Gallo-Payet, N; Lehoux, JG; Petit, A | 1 |
Archer, S; Bidlack, JM; Jiang, Q; Seyed-Mozaffari, A | 1 |
Brent, PJ; Cantarell, PA; Chahl, LA; Kavanagh, C | 1 |
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Suzuki, T | 1 |
de Costa, BR; Petrov, ES; Rice, KC; Robinson, SR; Smotherman, WP; Varlinskaya, EI | 1 |
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H | 1 |
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M | 1 |
Bodnar, RJ; Koch, JE | 1 |
Baumann, MH; Callahan, P; Rabii, J | 1 |
Józefowski, S; Płytycz, B | 1 |
Liu, H; Mazarati, A; Wasterlain, C | 1 |
Allescher, HD; Brechmann, C; Hahn, A; Schusdziarra, V; Storr, M | 1 |
Hall, FS; Mizoguchi, H; Nagase, H; Narita, M; Sora, I; Tseng, LF; Uhl, GR; Wu, HE | 1 |
Chen, J; Duman, RS; Nestler, EJ; Neve, R; Newton, SS; Sakai, N; Schlesinger, L; Shirayama, Y; Thome, J; Wallace, TL | 1 |
Buck, J; Loeb, J; Neudeck, BL | 1 |
Kimura, R; Kusaka, T; Urayama, A; Watanabe, Y; Yamada, S | 1 |
Ko, MC; Shi, YG; Watson, SJ; Woods, JH; Zhang, H | 1 |
Dickenson, JM; Fretwell, L | 1 |
Carlezon, WA; Chartoff, EH; Cohen, BM; Damez-Werno, D; Potter, DN | 1 |
Baraboi, ED; Guesdon, B; Hétu, M; Lopez, CA; Richard, D; Roffarello, BM | 1 |
Clark, JK; Hammond, S; Keralapurath, MM; Wagner, JJ | 1 |
Aranda-Fernández, PE; Chotro, MG; Gaztañaga, M | 1 |
Kissler, JL; Walker, BM | 1 |
Higashi, Y; Nakamura, K; Saito, M; Shimizu, S; Shimizu, T; Taniuchi, K; Ueba, T; Yawata, T | 1 |
Haji, A; Kimura, S; Ohi, Y | 1 |
Fan, W; Law, PY; Loh, HH; Xu, C; Zhang, Y | 1 |
Cruz, JS; de Macedo, FHP; Duarte, IDG; Ferreira, RCM; Gonçalves, WA; Gualdron, M; Machado, FS; Mahecha, GAB; Perez, AC; Rezende, BM; Romero, TRL | 1 |
Chai, JR; Du, WJ; Guo, LB; Li, QL; Liu, JG; Liu, R; Liu, ZQ; Sun, X; Wang, CY; Wang, YJ; Zan, GY | 1 |
42 other study(ies) available for naltrexone and binaltorphimine
Article | Year |
---|---|
Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
Topics: Animals; Chemical Phenomena; Chemistry; Cyclazocine; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ethylketocyclazocine; Guinea Pigs; Male; Mice; Models, Molecular; Morphine; Muscle, Smooth; Naltrexone; Receptors, Opioid; Receptors, Opioid, kappa; Structure-Activity Relationship | 1988 |
Kappa opioid mediation of fetal responses to milk.
Topics: Aging; Animals; Arousal; Chemoreceptor Cells; Dose-Response Relationship, Drug; Female; Fetal Movement; Gestational Age; Morphine; Motor Activity; Naloxone; Naltrexone; Pregnancy; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Sucking Behavior; Taste; Touch | 1992 |
Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
Topics: Analysis of Variance; Animals; Cerebral Ventricles; Dose-Response Relationship, Drug; Electroshock; Indoles; Injections, Intraventricular; Injections, Spinal; Male; Morphinans; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Spinal Cord | 1992 |
Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aging; Animals; Cyproheptadine; Female; Kinetics; Male; Naltrexone; Prolactin; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Sufentanil | 1992 |
Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Electroshock; Indoles; Injections, Spinal; Male; Morphinans; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Somatostatin; Spinal Cord | 1992 |
Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation.
Topics: Animals; Evoked Potentials; Hippocampus; Indoles; Male; Morphinans; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Somatostatin; Synapses; Time Factors | 1992 |
kappa-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury.
Topics: Animals; Blood Pressure; Brain Injuries; Magnesium; Magnetic Resonance Spectroscopy; Male; Naltrexone; Narcotic Antagonists; Phosphates; Phosphocreatine; Phosphorylation; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa | 1991 |
Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
Topics: Animals; Dynorphins; Indoles; Male; Mice; Morphinans; Morphine; Naltrexone; Pain; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Spine; Stereoisomerism | 1991 |
A study of central opioid receptor involvement in nitrous oxide analgesia in mice.
Topics: Analgesia; Animals; Binding, Competitive; Injections, Intraventricular; Injections, Spinal; Male; Mice; Naltrexone; Nitrous Oxide; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1990 |
Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Analgesics; Animals; Benzomorphans; Drug Tolerance; Electroshock; Indoles; Male; Mice; Mice, Inbred Strains; Morphinans; Morphine; Naltrexone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Stress, Psychological; Swimming | 1990 |
Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
Topics: Animals; Atrophy; Dynorphins; Hindlimb; Ischemia; Male; Naltrexone; Narcotic Antagonists; Paralysis; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Spinal Cord Diseases | 1989 |
Opioid components of the clockwork that governs luteinizing hormone and prolactin release in male rats.
Topics: Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Endorphins; Ligands; Luteinizing Hormone; Male; Naloxone; Naltrexone; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Opioid | 1988 |
Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Chemical Phenomena; Chemistry; Cyclazocine; Dynorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ethylketocyclazocine; Guinea Pigs; Male; Mice; Morphine; Naloxone; Naltrexone; Pyrrolidines; Rabbits; Receptors, Opioid; Receptors, Opioid, kappa | 1987 |
Neurotrophic factors in diabetic neuropathy.
Topics: Animals; Cells, Cultured; Diabetic Neuropathies; Ganglia, Spinal; Naloxone; Naltrexone; Nerve Growth Factors; Paclitaxel | 1995 |
The modulation of placental lactogen release by opioids: a role for extracellular calcium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenylate Cyclase Toxin; Analgesics; Calcium; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Ethylketocyclazocine; Gene Expression Regulation; Humans; Ionomycin; Naloxone; Naltrexone; Narcotics; Pertussis Toxin; Placental Lactogen; Pyrrolidines; Time Factors; Trophoblasts; Virulence Factors, Bordetella | 1993 |
Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in mice.
Topics: Acetates; Acetic Acid; Analgesics; Animals; Cattle; Corpus Striatum; Drug Interactions; Hydromorphone; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naltrexone; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1993 |
The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Behavior, Animal; Female; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine Dependence; Motor Activity; Muscle Contraction; Muscle, Smooth; Naloxone; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Antitussive effect of dihydroetorphine in mice.
Topics: Alkylating Agents; Animals; Antitussive Agents; Cough; Dose-Response Relationship, Drug; Etorphine; Injections, Intraperitoneal; Male; Mice; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Kappa opioid effects on fetal behavior: central administration of U50,488.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Brain; Dose-Response Relationship, Drug; Female; Fetal Movement; Gestational Age; Injections, Intraventricular; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1994 |
Antitussive effect of [Met5]enkephalin-Arg6-Phe7 in mice.
Topics: Animals; Antitussive Agents; Capsaicin; Cough; Dose-Response Relationship, Drug; Enkephalin, Methionine; Injections, Intraventricular; Male; Mice; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Effects of nor-binaltorphimine on butorphanol dependence.
Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats.
Topics: Animals; Arousal; Enkephalin, Leucine-2-Alanine; Feeding Behavior; Indoles; Male; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 1993 |
Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.
Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Female; Hypothalamus, Anterior; Lactation; Male; Median Eminence; Naltrexone; Neurons; Preoptic Area; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Sucking Behavior | 1996 |
Characterization of opiate binding sites on the goldfish (Carassius auratus L.) pronephric leukocytes.
Topics: Animals; Binding Sites; Goldfish; Leukocytes; Morphinans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, mu | 1997 |
Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus.
Topics: Action Potentials; Analgesics; Analgesics, Opioid; Animals; Disease Models, Animal; Dynorphins; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Immunohistochemistry; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Opioid Peptides; Peptide Fragments; Perforant Pathway; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Status Epilepticus | 1999 |
Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Endorphins; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Methionine; Ileum; In Vitro Techniques; Male; Morphine; Muscle, Smooth; Naltrexone; Narcotic Antagonists; Narcotics; Peristalsis; Rats; Rats, Wistar; Receptors, Opioid; Somatostatin | 2000 |
Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
Topics: Animals; beta-Endorphin; Binding, Competitive; Buprenorphine; Cell Membrane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Male; Medulla Oblongata; Mice; Mice, Knockout; Naltrexone; Narcotic Antagonists; Narcotics; Neurons; Peptide Fragments; Pons; Radioligand Assay; Receptors, Opioid; Receptors, Opioid, mu; Rhombencephalon; Sulfur Radioisotopes; Synaptic Transmission | 2002 |
Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cyclic AMP Response Element-Binding Protein; Depression; Dynorphins; Enkephalins; Helplessness, Learned; Immunohistochemistry; Male; Mice; Mice, Transgenic; Mutation; Naltrexone; Nucleus Accumbens; Prosencephalon; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2002 |
Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adjuvants, Immunologic; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Interleukin-1; Interleukin-8; Naltrexone; Receptors, Opioid, kappa; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.
Topics: Animals; Benzimidazoles; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Guanosine Triphosphate; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nociceptin Receptor; Opioid Peptides; Peptide Fragments; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord | 2003 |
Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Gene Expression Regulation; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Swimming | 2007 |
Role of large-conductance Ca(2+) -activated potassium channels in adenosine A(1) receptor-mediated pharmacological preconditioning in H9c2 cells.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caspase 3; Cell Death; Cell Hypoxia; Cell Line; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Ion Channel Gating; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Large-Conductance Calcium-Activated Potassium Channels; Myoblasts, Cardiac; Naltrexone; Phosphorylation; Protein Subunits; Proto-Oncogene Proteins c-akt; Rats; Receptor, Adenosine A1; Time Factors | 2009 |
Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
Topics: Animals; Cocaine; Cyclic AMP Response Element-Binding Protein; Diterpenes, Clerodane; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Male; Naltrexone; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation; Signal Transduction; Time Factors | 2011 |
Involvement of the opioid system in the orexigenic and hedonic effects of melanin-concentrating hormone.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Eating; Hypothalamic Hormones; Injections, Intraventricular; Male; Melanins; Models, Animal; Naltrexone; Narcotic Antagonists; Pituitary Hormones; Rats; Rats, Wistar; Receptors, Opioid; Sucrose; Taste | 2011 |
Cocaine- or stress-induced metaplasticity of LTP in the dorsal and ventral hippocampus.
Topics: Animals; Cocaine; Corticosterone; Dopamine Uptake Inhibitors; Drug Administration Schedule; Excitatory Postsynaptic Potentials; Hippocampus; Hormone Antagonists; In Vitro Techniques; Long-Term Potentiation; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Motor Activity; Naltrexone; Rats; Rats, Sprague-Dawley; Spironolactone; Stress, Psychological | 2014 |
Prenatal exposure to vanilla or alcohol induces crawling after these odors in the neonate rat: The role of mu and kappa opioid receptor systems.
Topics: Analysis of Variance; Animals; Animals, Newborn; Drug-Seeking Behavior; Ethanol; Female; Locomotion; Maternal Exposure; Naloxone; Naltrexone; Odorants; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Vanilla | 2015 |
Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
Topics: Administration, Intranasal; Alcoholism; Animals; Central Amygdaloid Nucleus; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Male; Motivation; Naltrexone; Narcotic Antagonists; Rats, Wistar; Receptors, Opioid, kappa; Self Administration; Substance Withdrawal Syndrome | 2016 |
Brain opioid and nociceptin receptors are involved in regulation of bombesin-induced activation of central sympatho-adrenomedullary outflow in the rat.
Topics: Adrenal Medulla; Animals; Bombesin; Brain; Catecholamines; Morphinans; Naloxone; Naltrexone; Nociceptin Receptor; Rats; Receptors, Opioid; Sympathetic Nervous System | 2016 |
Mechanisms of pentazocine-induced ventilatory depression and antinociception in anesthetized rats.
Topics: Analgesics; Anesthesia; Animals; Male; Naltrexone; Pentazocine; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Respiratory Insufficiency | 2016 |
Kappa opioid receptor controls neural stem cell differentiation via a miR-7a/Pax6 dependent pathway.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Dynorphins; Gene Expression Regulation, Developmental; Hippocampus; Humans; Mice; MicroRNAs; Naltrexone; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; PAX6 Transcription Factor; Receptors, Opioid, kappa; Signal Transduction | 2021 |
Endogenous opioid and cannabinoid systems modulate the muscle pain: A pharmacological study into the peripheral site.
Topics: Animals; Arachidonic Acids; Carrageenan; Cinnamates; Endocannabinoids; Hyperalgesia; Male; Monoacylglycerol Lipases; Morphine Derivatives; Myalgia; Naloxone; Naltrexone; Pain Measurement; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2021 |
Amygdala dynorphin/κ opioid receptor system modulates depressive-like behavior in mice following chronic social defeat stress.
Topics: Amygdala; Animals; Behavior, Animal; Depressive Disorder, Major; Dynorphins; Extracellular Signal-Regulated MAP Kinases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Proto-Oncogene Proteins c-fos; Receptors, Opioid, kappa; Social Behavior; Social Defeat | 2022 |